Sign In
Buy PACB
$1.15
-0.0350 (-2.95%)
At Close: Aug 10, 2026
PacBio Stock Down Despite Q1 Earnings & Revenue Beat Estimates
01:01pm, Friday, 09'th May 2025
Despite strong Service and other revenues, PACB reports soft first-quarter 2025 results partly due to lower Revio system shipments.
Pacific Biosciences (PACB) Reports Q1 Earnings: What Key Metrics Have to Say
10:00pm, Thursday, 08'th May 2025
While the top- and bottom-line numbers for Pacific Biosciences (PACB) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metri
Pacific Biosciences of California, Inc. (PACB) Q1 2025 Earnings Call Transcript
07:08pm, Thursday, 08'th May 2025
Pacific Biosciences of California, Inc. (NASDAQ:PACB ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Todd Friedman - Senior Director, Finance & Investor Relations Christ
Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates
06:31pm, Thursday, 08'th May 2025
Pacific Biosciences of California (PACB) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.26 per share a year ago.
PacBio Announces First Quarter 2025 Financial Results
04:15pm, Thursday, 08'th May 2025
MENLO PARK, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2025.
First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand
09:05am, Monday, 05'th May 2025
Collaboration leverages HiFi's unique ability to reveal hidden variants, bringing a new level of precision to early life genetic screening Collaboration leverages HiFi's unique ability to reveal hidde
Pacific Biosciences of California (PACB) Stock Falls Amid Market Uptick: What Investors Need to Know
07:20pm, Tuesday, 29'th Apr 2025
In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.11, marking a -1.77% move from the previous day.
PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry
09:05am, Monday, 28'th Apr 2025
Company licenses novel deep learning-based epigenetic models from CUHK enabling the detection of 5hmC, 5mC hemimethylation, and 6mA in standard sequencing runs Company licenses novel deep learning-bas
Pacific Biosciences of California (PACB) Flat As Market Gains: What You Should Know
07:21pm, Wednesday, 23'rd Apr 2025
In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.17, marking no change from the previous day.
International research team aims to develop better understanding of Alzheimer's disease and dementia in diverse populations International research team aims to develop better understanding of Alzheime
PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million
09:05am, Wednesday, 09'th Apr 2025
Implements Plan to Reduce Annualized Operating Expense Run Rate by $45 Million to $50 Million Q1 2025 Earnings Conference Call Scheduled for May 8, 2025 MENLO PARK, Calif., April 09, 2025 (GLOBE NE
PacBio Grants Equity Incentive Award to New Employee
07:45pm, Friday, 04'th Apr 2025
MENLO PARK, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee
Pacific Biosciences Names Jim Gibson Chief Financial Officer
09:22am, Thursday, 27'th Mar 2025
Pacific Biosciences of California has hired Jim Gibson as its new chief financial officer, effective March 31.
Jim Gibson to join PacBio as Chief Financial Officer
09:05am, Thursday, 27'th Mar 2025
MENLO PARK, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced Jim Gibson will join and be a
Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors
07:20pm, Thursday, 20'th Mar 2025
Pacific Biosciences of California (PACB) reachead $1.26 at the closing of the latest trading day, reflecting a +0.8% change compared to its last close.
